Vigonvita-B cuts outstanding H-shares by 0.08% via HK$10.60 million buyback

Bulletin Express11-04 17:24

Vigonvita Life Sciences Co., Ltd. (Vigonvita-B) submitted its Monthly Return to the Hong Kong Stock Exchange for the period ended 31 October 2026, detailing a modest contraction in share capital driven by on-market repurchases.

On 30 October 2026, the company repurchased 141,000 H-shares at an average price of HK$75.1413 per share, deploying approximately HK$10.60 million. The transaction reduced the number of issued H-shares (excluding treasury stock) to 166.76 million from 166.90 million, equivalent to a 0.08% decrease. All repurchased shares are being held as treasury stock.

Authorised share capital remained unchanged at 167.60 million shares of RMB1.00 par value, comprising 166.90 million H-shares listed in Hong Kong and 0.70 million unlisted ordinary shares. No share options, warrants, convertibles, or other equity instruments were issued, exercised, or cancelled during the month.

The company confirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment